The present invention relates to compounds and pharmaceutical compositions comprising said compounds for use in the treatment or prevention of an influenza virus infection. In particular, the disclosed compounds inhibit viral neuraminidase, preferably of influenza viruses resistant to known neuraminidase inhibitors.